About Us

Quay Pharmaceuticals is a privately owned CDMO working from FDA and MHRA inspected facilities. We are licenced to formulate and manufacture finished dosage forms for live biotherapeutics as well as small-large molecules. In the live biotherapeutic space, we work with consortia and single strain for drug delivery in oral, pessary and topical formats. Working as part of your team we rapidly and effectively bring products through development to First in Human studies to deliver success. We have worked on more than 50 plus strains from Phase I to Phase III projects and we are currently preparing for Commercial project.

Quay Pharma News

Quay Pharma Live Biotherapeutics Drug Delivery

Visit us on Facebook 


Team Members


Michael Kruidenier

Head of Business Development


Maireadh Pedersen

Chief Executive Officer


Ryan Wilson

Head of Live Bio Programme